• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2024 年阿尔茨海默病事实和数据。

2024 Alzheimer's disease facts and figures.

出版信息

Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.

DOI:10.1002/alz.13809
PMID:38689398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11095490/
Abstract

This article describes the public health impact of Alzheimer's disease (AD), including prevalence and incidence, mortality and morbidity, use and costs of care and the ramifications of AD for family caregivers, the dementia workforce and society. The Special Report discusses the larger health care system for older adults with cognitive issues, focusing on the role of caregivers and non-physician health care professionals. An estimated 6.9 million Americans age 65 and older are living with Alzheimer's dementia today. This number could grow to 13.8 million by 2060, barring the development of medical breakthroughs to prevent or cure AD. Official AD death certificates recorded 119,399 deaths from AD in 2021. In 2020 and 2021, when COVID-19 entered the ranks of the top ten causes of death, Alzheimer's was the seventh-leading cause of death in the United States. Official counts for more recent years are still being compiled. Alzheimer's remains the fifth-leading cause of death among Americans age 65 and older. Between 2000 and 2021, deaths from stroke, heart disease and HIV decreased, whereas reported deaths from AD increased more than 140%. More than 11 million family members and other unpaid caregivers provided an estimated 18.4 billion hours of care to people with Alzheimer's or other dementias in 2023. These figures reflect a decline in the number of caregivers compared with a decade earlier, as well as an increase in the amount of care provided by each remaining caregiver. Unpaid dementia caregiving was valued at $346.6 billion in 2023. Its costs, however, extend to unpaid caregivers' increased risk for emotional distress and negative mental and physical health outcomes. Members of the paid health care and broader community-based workforce are involved in diagnosing, treating and caring for people with dementia. However, the United States faces growing shortages across different segments of the dementia care workforce due to a combination of factors, including the absolute increase in the number of people living with dementia. Therefore, targeted programs and care delivery models will be needed to attract, better train and effectively deploy health care and community-based workers to provide dementia care. Average per-person Medicare payments for services to beneficiaries age 65 and older with AD or other dementias are almost three times as great as payments for beneficiaries without these conditions, and Medicaid payments are more than 22 times as great. Total payments in 2024 for health care, long-term care and hospice services for people age 65 and older with dementia are estimated to be $360 billion. The Special Report investigates how caregivers of older adults with cognitive issues interact with the health care system and examines the role non-physician health care professionals play in facilitating clinical care and access to community-based services and supports. It includes surveys of caregivers and health care workers, focusing on their experiences, challenges, awareness and perceptions of dementia care navigation.

摘要

本文描述了阿尔茨海默病(AD)对公共卫生的影响,包括其患病率和发病率、死亡率和发病率、护理的使用和成本,以及 AD 对家庭照顾者、痴呆症护理人员和整个社会的影响。这份特别报告讨论了针对有认知问题的老年人的更大的医疗保健系统,重点关注照顾者和非医师医疗保健专业人员的作用。目前,美国有 690 万 65 岁及以上的老年人患有阿尔茨海默病痴呆症。如果没有预防或治疗 AD 的医学突破,到 2060 年,这一数字可能会增长到 1380 万。在 2021 年,AD 的官方死亡证明记录了 119399 例 AD 死亡。2020 年和 2021 年,当 COVID-19 成为十大死因之一时,阿尔茨海默病是美国第七大死因。最近几年的官方统计数据仍在编纂中。在 65 岁及以上的美国人中,阿尔茨海默病仍然是第五大死因。在 2000 年至 2021 年间,中风、心脏病和艾滋病的死亡人数有所下降,而 AD 的报告死亡人数增加了 140%以上。2023 年,超过 1100 万家庭成员和其他无薪照顾者为患有阿尔茨海默病或其他痴呆症的人提供了约 184 亿小时的护理。这些数字反映了与十年前相比,照顾者人数的减少,以及每个剩余照顾者提供的护理量的增加。2023 年,无薪痴呆症护理的价值为 3466.6 亿美元。然而,其成本还包括无薪照顾者情绪困扰以及负面的精神和身体健康结果的风险增加。从事痴呆症诊断、治疗和护理的专业医疗保健人员和更广泛的社区为基础的劳动力都参与其中。然而,由于多种因素的综合影响,包括痴呆症患者绝对数量的增加,美国在不同痴呆症护理劳动力领域都面临着日益严重的短缺。因此,需要有针对性的项目和护理提供模式,以吸引、更好地培训和有效地部署医疗保健和社区为基础的工作人员,为痴呆症提供护理。医疗保险为 65 岁及以上患有 AD 或其他痴呆症的受益人的服务支付的人均费用几乎是为没有这些疾病的受益人的费用的三倍,而医疗补助计划的支付费用则超过 22 倍。预计 2024 年,为 65 岁及以上患有痴呆症的人提供的医疗、长期护理和临终关怀服务的总费用将达到 3600 亿美元。这份特别报告调查了认知问题老年人的照顾者如何与医疗保健系统互动,并研究了非医师医疗保健专业人员在促进临床护理以及获得社区服务和支持方面所发挥的作用。它包括对照顾者和医疗保健工作者的调查,重点关注他们的经验、挑战、对痴呆症护理导航的认识和看法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7e7991dba483/ALZ-20-3708-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/4690cb8925e5/ALZ-20-3708-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/550e24752fe0/ALZ-20-3708-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/d5c6f6686749/ALZ-20-3708-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/b1b7b885b547/ALZ-20-3708-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5de7d092fa56/ALZ-20-3708-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/2609122a1fdf/ALZ-20-3708-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/b4d853132cbf/ALZ-20-3708-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/28c0d97b8493/ALZ-20-3708-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/1e19334ea287/ALZ-20-3708-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/0b17b413b674/ALZ-20-3708-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/d6541b27b1be/ALZ-20-3708-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/b903054427f8/ALZ-20-3708-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5b343da8f956/ALZ-20-3708-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7164b288e339/ALZ-20-3708-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/0d8510f8f668/ALZ-20-3708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/98719432d7ae/ALZ-20-3708-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/22bb3cf23e25/ALZ-20-3708-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/eceb3b9610a7/ALZ-20-3708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/e9e2840db325/ALZ-20-3708-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/81052e5e8ed7/ALZ-20-3708-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/3b05796a39a3/ALZ-20-3708-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/ea8ab7839486/ALZ-20-3708-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/e3949cd8ac66/ALZ-20-3708-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/1dd7fa1b055f/ALZ-20-3708-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/cd35ae199335/ALZ-20-3708-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7eb86ef9de35/ALZ-20-3708-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5530d4a55569/ALZ-20-3708-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/e79bf3f1e17e/ALZ-20-3708-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/178fd56cbb7a/ALZ-20-3708-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/a32265c37b17/ALZ-20-3708-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5b48aa752b68/ALZ-20-3708-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7e0e632746d8/ALZ-20-3708-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/72e53e356e66/ALZ-20-3708-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/f022d3044a14/ALZ-20-3708-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7e7991dba483/ALZ-20-3708-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/4690cb8925e5/ALZ-20-3708-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/550e24752fe0/ALZ-20-3708-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/d5c6f6686749/ALZ-20-3708-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/b1b7b885b547/ALZ-20-3708-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5de7d092fa56/ALZ-20-3708-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/2609122a1fdf/ALZ-20-3708-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/b4d853132cbf/ALZ-20-3708-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/28c0d97b8493/ALZ-20-3708-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/1e19334ea287/ALZ-20-3708-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/0b17b413b674/ALZ-20-3708-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/d6541b27b1be/ALZ-20-3708-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/b903054427f8/ALZ-20-3708-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5b343da8f956/ALZ-20-3708-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7164b288e339/ALZ-20-3708-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/0d8510f8f668/ALZ-20-3708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/98719432d7ae/ALZ-20-3708-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/22bb3cf23e25/ALZ-20-3708-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/eceb3b9610a7/ALZ-20-3708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/e9e2840db325/ALZ-20-3708-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/81052e5e8ed7/ALZ-20-3708-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/3b05796a39a3/ALZ-20-3708-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/ea8ab7839486/ALZ-20-3708-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/e3949cd8ac66/ALZ-20-3708-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/1dd7fa1b055f/ALZ-20-3708-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/cd35ae199335/ALZ-20-3708-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7eb86ef9de35/ALZ-20-3708-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5530d4a55569/ALZ-20-3708-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/e79bf3f1e17e/ALZ-20-3708-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/178fd56cbb7a/ALZ-20-3708-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/a32265c37b17/ALZ-20-3708-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/5b48aa752b68/ALZ-20-3708-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7e0e632746d8/ALZ-20-3708-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/72e53e356e66/ALZ-20-3708-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/f022d3044a14/ALZ-20-3708-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98fa/11095490/7e7991dba483/ALZ-20-3708-g012.jpg

相似文献

1
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
2
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
3
2022 Alzheimer's disease facts and figures.2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
4
2021 Alzheimer's disease facts and figures.2021 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2021 Mar;17(3):327-406. doi: 10.1002/alz.12328. Epub 2021 Mar 23.
5
2020 Alzheimer's disease facts and figures.2020年阿尔茨海默病事实与数据。
Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.
6
2014 Alzheimer's disease facts and figures.2014 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2014 Mar;10(2):e47-92. doi: 10.1016/j.jalz.2014.02.001.
7
2013 Alzheimer's disease facts and figures.2013 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2013 Mar;9(2):208-45. doi: 10.1016/j.jalz.2013.02.003.
8
2015 Alzheimer's disease facts and figures.2015 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2015 Mar;11(3):332-84. doi: 10.1016/j.jalz.2015.02.003.
9
2016 Alzheimer's disease facts and figures.2016 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001.
10
2012 Alzheimer's disease facts and figures.2012 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2012;8(2):131-68. doi: 10.1016/j.jalz.2012.02.001.

引用本文的文献

1
Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment.PrecivityAD2™血液检测用于识别认知障碍个体脑淀粉样蛋白病变存在与否的独立验证。
NPJ Dement. 2025;1(1):23. doi: 10.1038/s44400-025-00026-y. Epub 2025 Sep 4.
2
Effects of Diabetes Mellitus on Motor and Non-Motor Symptoms in Parkinson's Disease: A Cross-Sectional Study.糖尿病对帕金森病运动和非运动症状的影响:一项横断面研究。
Rev Neurol. 2025 Aug 27;80(7):38630. doi: 10.31083/RN38630.
3
Associations between comorbid conditions with mild cognitive impairment and Alzheimer's disease by race-ethnicity and sex based on NACC data.

本文引用的文献

1
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population.美国医疗保险人群初级保健中轻度认知障碍的检出率。
J Prev Alzheimers Dis. 2024;11(1):7-12. doi: 10.14283/jpad.2023.131.
2
Estimating prevalence of early symptomatic Alzheimer's disease in the United States.美国早期有症状阿尔茨海默病患病率的估计
Alzheimers Dement (Amst). 2023 Nov 27;15(4):e12497. doi: 10.1002/dad2.12497. eCollection 2023 Oct-Dec.
3
Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset.
基于国家阿尔茨海默病协调中心(NACC)数据,按种族和性别划分的轻度认知障碍及阿尔茨海默病共病情况之间的关联。
Alzheimers Dement. 2025 Sep;21(9):e70650. doi: 10.1002/alz.70650.
4
Association of Urinary Iodine Concentration With Cognitive Function Among Older Adults: NHANES 2011-2014.老年人尿碘浓度与认知功能的关联:2011 - 2014年美国国家健康与营养检查调查(NHANES)
Food Sci Nutr. 2025 Sep 3;13(9):e70906. doi: 10.1002/fsn3.70906. eCollection 2025 Sep.
5
Alzheimer disease is (sometimes) highly heritable: Drivers of variation in heritability estimates for binary traits, a systematic review.阿尔茨海默病(有时)具有高度遗传性:二元性状遗传力估计值变异的驱动因素,一项系统综述。
PLoS Genet. 2025 Sep 4;21(9):e1011701. doi: 10.1371/journal.pgen.1011701.
6
ApoE4 Upregulates GSK-3β to Aggravate Alzheimer-Like Pathologies and Cognitive Impairment in Type 2 Diabetic Mice.载脂蛋白E4上调糖原合成酶激酶-3β以加重2型糖尿病小鼠的阿尔茨海默病样病理改变和认知障碍。
CNS Neurosci Ther. 2025 Sep;31(9):e70575. doi: 10.1111/cns.70575.
7
Disarming COX-1 to disrupt Alzheimer's inflammatory trajectory: preclinical insights and translational promise.抑制COX-1以破坏阿尔茨海默病的炎症进程:临床前见解与转化前景
Transl Neurodegener. 2025 Sep 2;14(1):46. doi: 10.1186/s40035-025-00509-1.
8
Novel Pathological Mechanisms Revealed by Spatial Transcriptomic Analysis of Hippocampus in Aged Control, Primary Age-Related Tauopathy, and Alzheimer's Disease.通过对老年对照、原发性年龄相关性tau蛋白病和阿尔茨海默病海马体的空间转录组分析揭示的新病理机制
Res Sq. 2025 Aug 22:rs.3.rs-7303622. doi: 10.21203/rs.3.rs-7303622/v1.
9
Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care: A Prespecified Analysis of the Dementia Care Study (D-CARE) Randomized Clinical Trial.卫生系统、社区及常规痴呆症护理的患者及照护者结局:痴呆症护理研究(D-CARE)随机临床试验的预设分析
JAMA Intern Med. 2025 Sep 2. doi: 10.1001/jamainternmed.2025.4247.
10
Tenascin-R aggravates Aβ production in the perforant pathway by regulating Nav1.6 activity in APP/PS1 mice.腱生蛋白-R通过调节APP/PS1小鼠穿通通路中的Nav1.6活性来加重Aβ生成。
Alzheimers Dement. 2025 Sep;21(9):e70633. doi: 10.1002/alz.70633.
痴呆症发病前后临床诊断的风险与益处
Gerontol Geriatr Med. 2023 Nov 22;9:23337214231213185. doi: 10.1177/23337214231213185. eCollection 2023 Jan-Dec.
4
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.生命末期有和没有痴呆症的 Medicare 受益人生存治疗。
J Alzheimers Dis. 2023;96(3):1183-1193. doi: 10.3233/JAD-230692.
5
Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.饮食在改变阿尔茨海默病风险中的作用:历史和现有认识。
J Alzheimers Dis. 2023;96(4):1353-1382. doi: 10.3233/JAD-230418.
6
Cognitive Impairment in Sexual and Gender Minority Groups: A Scoping Review of the Literature.性少数群体的认知障碍:文献综述的范围
LGBT Health. 2024 Apr;11(3):178-192. doi: 10.1089/lgbt.2023.0095. Epub 2023 Oct 12.
7
Identification of Dementia in Medicare Claims Compared to Rigorous Clinical Assessments in African Americans.与严格的临床评估相比,医疗保险索赔中对非裔美国人的痴呆症识别。
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad235.
8
Care Ecosystem Collaborative Model and Health Care Costs in Medicare Beneficiaries With Dementia: A Secondary Analysis of a Randomized Clinical Trial.Care Ecosystem 协作模式与痴呆 Medicare 受益人的医疗保健费用:一项随机临床试验的二次分析。
JAMA Intern Med. 2023 Nov 1;183(11):1222-1228. doi: 10.1001/jamainternmed.2023.4764.
9
The intersection of social determinants of health and family care of people living with Alzheimer's disease and related dementias: A public health opportunity.健康的社会决定因素与阿尔茨海默病和相关痴呆症患者家庭护理的交集:公共卫生的机遇。
Alzheimers Dement. 2023 Dec;19(12):5837-5846. doi: 10.1002/alz.13437. Epub 2023 Sep 12.
10
Change in Caregiving to Older Adults During the COVID-19 Pandemic: Differences by Dementia Status.COVID-19 大流行期间对老年人大护理的变化:痴呆症状况的差异。
J Appl Gerontol. 2023 Dec;42(12):2277-2282. doi: 10.1177/07334648231197514. Epub 2023 Sep 8.